Channel Therapeutics Corp...

NYSE: PTHS · Real-Time Price · USD
22.73
0.14 (0.62%)
At close: Aug 26, 2025, 1:16 PM
22.60
-0.59%
After-hours: Aug 26, 2025, 06:00 PM EDT

Channel Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024
Cash & Equivalents
59.17K 131.32K 513.44K 1.25M 2.41M 3.77M
Short-Term Investments
n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a
Receivables
40.4K 40.4K 40.4K 40.4K 40.4K 40.4K
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
710.94K 723.13K 750K 750K n/a n/a
Total Current Assets
822.85K 911.18K 1.37M 2.14M 2.6M 4.03M
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
n/a n/a n/a n/a n/a n/a
Total Assets
822.85K 911.18K 1.37M 2.14M 2.6M 4.03M
Account Payables
4.99M 2.6M 1.9M 1.28M 835.41K 2.41M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
2.3M 2.5M 2.19M 2.29M 1.59M n/a
Other Current Liabilities
23.64K n/a n/a 308.00 363.43K 493.92K
Total Current Liabilities
7.32M 5.11M 4.08M 3.57M 2.79M 2.9M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a n/a n/a n/a n/a
Total Liabilities
7.32M 5.11M 4.08M 3.57M 2.79M 2.9M
Total Debt
2.3M 2.5M 2.19M 2.29M 1.59M n/a
Common Stock
67.00 621.00 613.00 583.00 584.00 578.00
Retained Earnings
-26.89M -23.44M -21.47M -19.55M -17.85M -16.08M
Comprehensive Income
n/a n/a n/a n/a n/a n/a
Shareholders Equity
-6.49M -4.2M -2.71M -1.43M -182.52K 1.13M
Total Investments
n/a n/a n/a n/a n/a n/a